French Consortium Pioneers New AMR Development Model
A new consortium that has won funding from the French government will focus on developing new treatments, diagnostics and surveillance and make sure that these approaches are properly valued by involving health economists in new drug development.
You may also be interested in...
The EU regulator says it supports a globally aligned approach to the development of new antimicrobial medicines.
G7 countries should look to US PASTEUR Act For Inspiration On Pull Incentives for Antimicrobials
PASTEUR Act in the US is the most promising initiative out there to address antimicrobial resistance.